PMC:7696151 / 86053-86239
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2538 | 15-23 | Species | denotes | patients | Tax:9606 |
| 2553 | 153-156 | Chemical | denotes | HCQ | MESH:D006886 |
| 2554 | 161-171 | Chemical | denotes | bortezomib | MESH:D000069286 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T547 | 0-186 | Sentence | denotes | Among eligible patients, 14% experienced a very good response, 14% minor responses, and 45% a period of stability in the disease when the association of HCQ and bortezomib were provided. |